| ACTUATE THERAPEUTICS, INC. |
Director, 10%+ Owner |
Common Stock |
873,033 |
$6,477,904 |
$7.42 |
05 Jan 2026 |
By Kairos Venture Opportunities I, L.P. |
| ACTUATE THERAPEUTICS, INC. |
Director, 10%+ Owner |
Common Stock |
904,795 |
$5,247,811 |
$5.80 |
05 Jan 2026 |
By Kairos Venture Partners II, L.P. |
| ACTUATE THERAPEUTICS, INC. |
Director, 10%+ Owner |
Common Stock |
321,781 |
$2,387,615 |
$7.42 |
05 Jan 2026 |
By Kairos SPV Fund, LLC |
| ACTUATE THERAPEUTICS, INC. |
Director, 10%+ Owner |
Common Stock |
254,735 |
$1,890,133 |
$7.42 |
05 Jan 2026 |
By Kairos-Actuate SPV, L.P. |
| Chardan NexTech Acquisition 2 Corp. |
Director |
Common Stock, par value $0.0001 |
22,000 |
$94,160 |
$4.28 |
10 Aug 2021 |
Direct |
| ACTUATE THERAPEUTICS, INC. |
Director, 10%+ Owner |
Stock Options |
15,000 |
|
|
22 May 2025 |
Direct |